MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, Invizyne Technologies, Inc. (Invizyne). The Company's segments include broker dealer & intellectual property service, and technology development.
The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence.
The technology development segment has one subsidiary, Invizyne. Invizyne is a research and development stage synthetic biology company. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 8.4K | 
| Three Month Average Volume | 254.9K | 
| High Low | |
| Fifty-Two Week High | 21.67 USD | 
| Fifty-Two Week Low | 7.0001 USD | 
| Fifty-Two Week High Date | 21 Sep 2023 | 
| Fifty-Two Week Low Date | 27 Jun 2024 | 
| Price and Volume | |
| Current Price | 8.095 USD | 
| Beta | -100,000 | 
| Relative Price Change | |
| Four Week Relative Price Change | -26.11% | 
| Thirteen Week Relative Price Change | -12.05% | 
| Twenty-Six Week Relative Price Change | -35.98% | 
| Fifty-Two Week Relative Price Change | -99,999.99% | 
| Year-to-Date Relative Price Change | -40.74% | 
| Price Change | |
| One Day Price Change | -2.12% | 
| Thirteen Week Price Change | -5.87% | 
| Twenty-Six Week Price Change | -29.61% | 
| Five Day Price Change | -1.36% | 
| Fifty-Two Week Price Change | -99,999.99% | 
| Year-to-Date Price Change | -29.82% | 
| Month-to-Date Price Change | -17.06% | 
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 4.01402 USD | 
| Book Value Per Share (Most Recent Quarter) | 3.54821 USD | 
| Tangible Book Value Per Share (Last Fiscal Year) | 4.01402 USD | 
| Tangible Book Value Per Share (Most Recent Quarter) | 3.54821 USD | 
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -2.53683 USD | 
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.74637 USD | 
| Revenue Per Share (Trailing Twelve Months) | 0.20451 USD | 
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD | 
| Dividend Per Share (Trailing Twelve Months) | 0 USD | 
| Dividend Per Share (5 Year) | -99999.99 USD | 
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.86042 USD | 
| Excluding Extraordinary Items (Trailing Twelve Months) | -2.21651 USD | 
| Normalized (Last Fiscal Year) | -0.85641 USD | 
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.86042 USD | 
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -2.21651 USD | 
| Including Extraordinary Items (Last Fiscal Year) | -0.86042 USD | 
| Including Extraordinary Items (Trailing Twelve Months) | -2.21651 USD | 
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.79152 USD | 
| Cash Per Share (Most Recent Quarter) | 2.20552 USD | 
| Cash Flow Per Share (Last Fiscal Year) | -0.92783 USD | 
| Cash Flow Per Share (Trailing Twelve Months) | -2.38608 USD | 
| Free Cash Flow Per Share (Trailing Twelve Months) | -1.18144 USD | 
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -100,000 | 
| Cash Flow Revenue (Trailing Twelve Months) | -578 | 
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -1,190.26% | 
| Pretax Margin (Last Fiscal Year) | -125.46% | 
| Pretax Margin (5 Year) | -99,999.99% | 
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | -99,999.99% | 
| Gross Margin (Trailing Twelve Months) | -99,999.99% | 
| Gross Margin (5 Year) | -99,999.99% | 
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -140.66% | 
| Operating Margin (Trailing Twelve Months) | -1,256.28% | 
| Operating Margin (5 Year) | -99,999.99% | 
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -127.57% | 
| Net Profit Margin (Trailing Twelve Months) | -1,179.83% | 
| Net Profit Margin (5 Year) | -99,999.99% | 
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% | 
| Tangible Book Value (5 Year) | -99,999.99% | 
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% | 
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -60.06% | 
| Revenue Growth (3 Year) | -99,999.99% | 
| Revenue Change (Trailing Twelve Months) | -74.04% | 
| Revenue Per Share Growth | -99,999.99% | 
| Revenue Growth (5 Year) | 20.53% | 
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% | 
| Total Debt (5 Year) | -99,999.99% | 
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% | 
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -201.30% | 
| EPS Change (Trailing Twelve Months) | -7,585.54% | 
| EPS Growth (3 Year) | -99,999.99% | 
| EPS Growth (5 Year) | -99,999.99% | 
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% | 
| EBITDA (5 Year Interim) | -99,999.99% | 
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% | 
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 2 | 
| Price to Tangible Book (Most Recent Quarter) | 2 | 
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 | 
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 | 
| Net Debt | |
| Net Debt (Most Recent Quarter) | -20,501,680 | 
| Net Debt (Last Fiscal Year) | -7,357,690 | 
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 12 | 
| Price to Sales (Trailing Twelve Months) | 41 | 
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 | 
| PE Normalized (Last Fiscal Year) | -100,000 | 
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 | 
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 | 
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 | 
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 | 
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% | 
| Dividend Yield | -99,999.99% | 
| Current Dividend Yield | 0.00% | 
| Price to Book | |
| Price to Book (Last Fiscal Year) | 2 | 
| Price to Book (Most Recent Quarter) | 2 | 
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 | 
| Long Term Debt to Equity (Most Recent Quarter) | 0 | 
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% | 
| Payout Ratio (Trailing Twelve Months) | -99,999.99% | 
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | -100,000 | 
| Quick Ratio (Most Recent Quarter) | -100,000 | 
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 | 
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 | 
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | -100,000 | 
| Current Ratio (Most Recent Quarter) | -100,000 | 
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -7,599,820 | 
| Free Cash Flow (Trailing Twelve Months) | -10,552,740 | 
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 | 
| Net Interest Coverage (Trailing Twelve Months) | -100,000 | 
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 | 
| Total Debt to Equity (Most Recent Quarter) | 0 | 
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -22.45% | 
| Return on Assets (Trailing Twelve Months) | -66.19% | 
| Return on Assets (5 Year) | -99,999.99% | 
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -23.25% | 
| Return on Equity (Trailing Twelve Months) | -70.08% | 
| Return on Equity (5 Year) | -99,999.99% | 
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -25.57% | 
| Return on Investment (Trailing Twelve Months) | -74.67% | 
| Return on Investment (5 Year) | -99,999.99% |